PSC
VCYT icon

Piper Sandler & Co’s Veracyte VCYT Stock Holding History

Piper Sandler & Co’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-10,000
Closed -$47K – 69
2015
Q3 		$47K Buy
+10,000
New +$95.2K 0.05% 94
2015
Q2 		– Sell
-20,000
Closed -$146K – 117
2015
Q1 		$146K Sell
20,000
-5,250
-21% -$43K 0.06% 100
2014
Q4 		$244K Buy
+25,250
New +$197K 0.12% 77

Other funds holding VCYT

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
CCP
Clough Capital Partners Boston, Massachusetts $1.04B AUM 49.7% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
GPGA
Grandeur Peak Global Advisors Salt Lake City, Utah $427M AUM 39.14% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Piper Sandler & Co's VCYT Position: Q4 2015 in Review

Piper Sandler & Co sold out of Veracyte (VCYT) in Q4 2015, closing a stake of 10,000 shares — an estimated $47K sold.

Piper Sandler & Co first reported a position in VCYT in Q4 2014 and held it in 3 quarters. The position peaked at $244K in Q4 2014. 64 funds tracked by Wall St. Rank hold VCYT as of Q4 2015.

  • Piper Sandler & Co reported no remaining Veracyte position as of Q4 2015 after selling out during the quarter.
  • Piper Sandler & Co sold 10,000 Veracyte shares in Q4 2015, an estimated $47K.
  • Piper Sandler & Co first reported a position in Veracyte in Q4 2014 and held it in 3 quarters.
  • Piper Sandler & Co's Veracyte position peaked at $244K in Q4 2014.
  • 64 funds tracked by Wall St. Rank held Veracyte as of Q4 2015.

Based on Piper Sandler & Co's 13F filing for Q4 2015, filed 16 Feb 2016.